London
United Kingdom
2
2018-12-27
2
2020-08-11
These are the the leading inventors for applications assigned to Ixogen Ltd.:
Ixogen Ltd. based in London, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#2 | 2015-11-05 β Patent 10,047,347 granted on 2018-08-14Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
Also check out Ixogen Ltd.'s (London, United Kingdom) applicant profile with 2 patent applications submitted.
101367 β